Javascript must be enabled to continue!
A life for autoimmune blistering diseases: in memoriam Detlef Zillikens
View through CrossRef
Detlef Zillikens, MD, director and chair of the Department of Dermatology at the University of Lübeck, Lübeck, Germany, died in September 2022, aged only 64. He dedicated his professional life to autoimmune blistering diseases (AIBDs) and built his department into one of the world’s leading centers for these diseases. Herein, his professional life and the impact on the field of AIBDs and the research landscape at the University of Lübeck are addressed. With his warm, integrative, open-minded, ever-optimistic attitude, he was a highly reliable colleague, mentor, and friend to many in the field including each of the authors. Combined with his in-depth knowledge of dermatology, interest in many fields of life science, and hard work, Detlef Zillikens initiated the founding of two independent research institutes, the Lübeck Institute of Experimental Dermatology and the Institute and Comprehensive Center for Inflammation Medicine. He was also instrumental in establishing the Center for Research on Inflammation of the Skin, where in a new research building, over 140 scientists pursue research questions related to skin inflammation. By inviting numerous researchers and clinicians to his department and hosting two large international meetings, he brought the field of AIBDs much closer together and inspired multiple national and international research initiatives. His ideas will live on and grow in many of his colleagues and mentees.
Frontiers Media SA
Jennifer E. Hundt
Christian D. Sadik
Nina van Beek
Hauke Busch
Frédéric Caux
Matthias Goebeler
Christoph M. Hammers
Karin Hartmann
Takashi Hashimoto
Saleh Ibrahim
Michael Kasperkiewicz
Dedee F. Murrell
Andreas Recke
Christian Rose
Nina Schumacher
Iakov Shimanovich
Cassian Sitaru
Patrick Terheyden
Diamant Thaçi
Ralf J. Ludwig
Enno Schmidt
Title: A life for autoimmune blistering diseases: in memoriam Detlef Zillikens
Description:
Detlef Zillikens, MD, director and chair of the Department of Dermatology at the University of Lübeck, Lübeck, Germany, died in September 2022, aged only 64.
He dedicated his professional life to autoimmune blistering diseases (AIBDs) and built his department into one of the world’s leading centers for these diseases.
Herein, his professional life and the impact on the field of AIBDs and the research landscape at the University of Lübeck are addressed.
With his warm, integrative, open-minded, ever-optimistic attitude, he was a highly reliable colleague, mentor, and friend to many in the field including each of the authors.
Combined with his in-depth knowledge of dermatology, interest in many fields of life science, and hard work, Detlef Zillikens initiated the founding of two independent research institutes, the Lübeck Institute of Experimental Dermatology and the Institute and Comprehensive Center for Inflammation Medicine.
He was also instrumental in establishing the Center for Research on Inflammation of the Skin, where in a new research building, over 140 scientists pursue research questions related to skin inflammation.
By inviting numerous researchers and clinicians to his department and hosting two large international meetings, he brought the field of AIBDs much closer together and inspired multiple national and international research initiatives.
His ideas will live on and grow in many of his colleagues and mentees.
Related Results
Prospective analysis of the incidence of autoimmune bullous disorders in Lower Franconia, Germany
Prospective analysis of the incidence of autoimmune bullous disorders in Lower Franconia, Germany
Summary Background: Only limited epidemiologic data are available on autoimmune bullous diseases. Improved diagnostic tools should have led to an increased incidence. To test this ...
Autoimmune diseases in children and anesthesia
Autoimmune diseases in children and anesthesia
Autoimmune diseases in children may be linked to genetic, environmental, and hormonal factors. It’s estimated that 5% of children worldwide have at least one autoimmune condition, ...
Two Rare Cases of Severe Autoimmune Dyserythropoiesis without Any Underlying Haematological Malignancy or Autoimmune Disease
Two Rare Cases of Severe Autoimmune Dyserythropoiesis without Any Underlying Haematological Malignancy or Autoimmune Disease
Background:
Autoimmune dyserythropoiesis is a rare disorder with only 4 adult cases and 3 paediatric cases reported in the literature. These suggest an underlying ca...
TYPE 2 DIABETES MELLITUS – AN AUTOIMMUNE DISEASE?
TYPE 2 DIABETES MELLITUS – AN AUTOIMMUNE DISEASE?
In recent years, the association of type 2 diabetes mellitus (DM) to autoimmune diseases has been discussed. Participation of innate immunity in the development of inflammation in ...
Blistering Disorders of the Foot
Blistering Disorders of the Foot
ABSTRACT
Multiple pathophysiologic and biomolecular processes lead to bullae, including disruption of adhesion molecules, accumulation of cell injury, and traumatic injur...
Abstract 5051: Associations between autoimmune conditions and gastric cancer risk among elderly US adults
Abstract 5051: Associations between autoimmune conditions and gastric cancer risk among elderly US adults
Abstract
Background: The associations of multiple autoimmune conditions with gastric cancer may reflect their co-occurrence with autoimmune gastritis and its clinica...
Intestinal Mucosal Immunity Caused Autoimmune Diseases
Intestinal Mucosal Immunity Caused Autoimmune Diseases
Autoimmune diseases are a group of chronic inflammatory disorders caused by the imbalance of immune homeostasis and abnormal production of autoantibodies. The etiology of autoimmun...
Gelatinase B–deficient Mice Are Resistant to Experimental Bullous Pemphigoid
Gelatinase B–deficient Mice Are Resistant to Experimental Bullous Pemphigoid
Bullous pemphigoid (BP) is an autoimmune subepidermal blistering disease characterized by deposition of autoantibodies at the basement membrane zone. In an experimental BP model in...

